Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 7;11(9):1461.
doi: 10.3390/vaccines11091461.

Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022

Jubby Marcela Gálvez  1 , Ángela María Pinzón-Rondón  2 , Henry Mauricio Chaparro-Solano  2 , Hanna Valentina Tovar-Romero  2 , Juliana Ramírez-Prieto  2 , Sergio Andrés Ortigoza-Espitia  2 , Ángela María Ruiz-Sternberg  2
Affiliations

Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022

Jubby Marcela Gálvez et al. Vaccines (Basel). .

Abstract

Vaccination has proven to be one of the most effective strategies against the COVID-19 pandemic. Several studies have evaluated and confirmed its effectiveness in different populations, particularly in reducing severe outcomes such as hospitalization and death. Some studies have investigated the effectiveness of vaccination against the infection, identifying the need for booster doses. This study aimed to explore the effectiveness of the vaccination schedule on the probability of infection in a sample of Colombian patients during the fourth wave of the COVID-19 pandemic, which was associated with the emergence and predominance of the Omicron variant. A cross-sectional study was conducted on individuals who underwent RT-PCR testing for COVID-19 detection in a dedicated laboratory in Bogotá, Colombia, between 30 December 2021 and 7 February 2022. A total of 1468 subjects was included in the study, of whom 36.6% (n = 538) had a positive PCR test for COVID-19. The comparison between fully vaccinated individuals with a booster dose and those without the booster dose revealed a 28% reduction in the odds of infection (OR = 0.719 CI 0.531-0.971). Age (OR = 1.009 CI 1.001-1.018) and low economic status (OR = 1.812 CI 1.416-2.319) were associated with an increased risk of infection. These findings suggest the need for a booster vaccination in the general population to improve the prevention rates of SARS-CoV-2 infection and mitigate severe outcomes.

Keywords: COVID-19; Colombia; booster dose; effectiveness; vaccination strategy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Raman R., Patel K.J., Ranjan K. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules. 2021;11:993. doi: 10.3390/biom11070993. - DOI - PMC - PubMed
    1. Ranzani O.T., Hitchings M.D.T., Dorion M., D’Agostini T.L., De Paula R.C., De Paula O.F.P., Villela E.F.D.M., Torres M.S.S., De Oliveira S.B., Schulz W., et al. Effectiveness of the CoronaVac Vaccine in Older Adults during a Gamma Variant Associated Epidemic of COVID-19 in Brazil: Test Negative Case-Control Study. BMJ. 2021;374:n2015. doi: 10.1136/bmj.n2015. - DOI - PMC - PubMed
    1. Lauring A.S., Tenforde M.W., Chappell J.D., Gaglani M., Ginde A.A., McNeal T., Ghamande S., Douin D.J., Talbot H.K., Casey J.D., et al. Clinical Severity of, and Effectiveness of MRNA Vaccines against, COVID-19 from Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: Prospective Observational Study. BMJ. 2022;376:e069761. doi: 10.1136/bmj-2021-069761. - DOI - PMC - PubMed
    1. World Health Organization Colombia Situation. [(accessed on 29 June 2023)]; Available online: https://covid19.who.int/region/amro/country/co.
    1. Ruiz-Sternberg Á.M., Chaparro-Solano H.M., Albornóz L.L., Pinzón-Rondón Á.M., Pardo-Oviedo J.M., Molano-González N., Otero-Rodríguez D.A., Zapata-Gómez F.A., Gálvez J.M. Genomic Characterization of SARS-CoV-2 and Its Association with Clinical Outcomes: A 1-Year Longitudinal Study of the Pandemic in Colombia. Int. J. Infect. Dis. 2022;116:91–100. doi: 10.1016/j.ijid.2021.12.326. - DOI - PMC - PubMed

LinkOut - more resources